A New Next‐Generation Sequencing Approach in Human Cytomegalovirus for the Identification of Antiviral Resistance Mutations and Genotypic Classification
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Maria Arnedo-Muñoz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Univ…. Hauptthemen laut MEDLINE: Cytomegalovirus, High-Throughput Nucleotide Sequencing, Drug Resistance, Viral, Antiviral Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study introduces a new procedure for antiviral resistance analysis and genetic classification of human cytomegalovirus (HCMV) using next‐generation sequencing (NGS) adapted to existing methodologies, aiming for more targets due to the recent use of new antivirals. It expands the classical investigation of mutations in UL54 and UL97 genes, associated with resistance to (val)ganciclovir, foscarnet and cidofovir, to include UL27, UL56 and UL89 genes, which target newer antivirals like maribavir and letermovir. Additionally, it includes the genetic analysis of UL55 (glycoprotein B) for genotype classification. This new methodology involves multiplex‐PCR for DNA enrichment, followed by NGS using Illumina MiSeq platform and data analysis through an in‐house pipeline. Several validations were performed by firstly using genome sequence from wild‐type sensitive reference strain (AD‐169), secondly comparing to previously characterized samples by Sanger, and lastly the use of external quality controls. A new NGS technique based on amplicons approach has been developed. Validation using wild‐type control material showed 100% identity with the reference genome across all replicates. Only one minority variant was detected in one replicate. Compared to Sanger sequencing, NGS revealed additional low‐frequency mutations not detected by Sanger, without impacting resistance interpretation. The method also performed reliably in external quality assessment controls. Moreover, the detection limit of the technique was established at 17 894.60 IU/mL. Finally, this approach enabled the identification of HCMV genotypes. This approach improves the monitoring of antiviral resistance and viral diversity, enhancing early clinical decision‐making in immunocompromised patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Department of Genetics and Microbiology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
- CIBER Hepatic and Digestive Diseases (CIBERehd), Instituto Carlos III, Madrid, Spain.
- Infectious Diseases Department, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Bellaterra, Spain.
- Centro de Investigación Biomédica en red de Enfermedades Infecciosas CIBERINFEC, Instituto Carlos III, Madrid, Spain.
- Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Infantil. Vall d'Hebron Barcelona Hospital Campus, Institut de Recerca Vall d'Hebron, Barcelona, Spain.
ORCID-Profile: Maria Arnedo-Muñoz
Zitieren
APA
Arnedo-Muñoz, M., Prats-Méndez, I., Gónzalez-Sánchez, A., Martín, M. C., Rando-Segura, A., Arcos, I. L., Nadal-Barón, P., Saubi, N., Mendoza-Palomar, N., Bernat-Sole, M., Albasanz-Puig, A., Piñana, M., Andrés, C., Melendo-Pérez, S., Larrosa, N., Antón, A., & Esperalba, J. (2025). A New Next‐Generation Sequencing Approach in Human Cytomegalovirus for the Identification of Antiviral Resistance Mutations and Genotypic Classification. Journal of Medical Virology. https://doi.org/10.1002/jmv.70523
Vancouver
Arnedo-Muñoz M, Prats-Méndez I, Gónzalez-Sánchez A, Martín MC, Rando-Segura A, Arcos IL, et al. A New Next‐Generation Sequencing Approach in Human Cytomegalovirus for the Identification of Antiviral Resistance Mutations and Genotypic Classification. Journal of Medical Virology. 2025. doi:10.1002/jmv.70523
BibTeX
@article{ArnedoMuoz2025,
author = {Arnedo-Muñoz, Maria and Prats-Méndez, Ignasi and Gónzalez-Sánchez, Alejandra and Martín, Maria Carmen and Rando-Segura, Ariadna and Arcos, Ibai Los and Nadal-Barón, Patricia and Saubi, Narcís and Mendoza-Palomar, Natalia and Bernat-Sole, Marta and Albasanz-Puig, Adaia and Piñana, Maria and Andrés, Cristina and Melendo-Pérez, Susana and Larrosa, Nieves and Antón, Andrés and Esperalba, Juliana},
title = {A New Next‐Generation Sequencing Approach in Human Cytomegalovirus for the Identification of Antiviral Resistance Mutations and Genotypic Classification},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70523}
}
EUVIMED